Last Updated: May 3, 2026

Litigation Details for Sotera Wireless, Inc. (Bankr. S.D. Cal. 2016)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Sotera Wireless, Inc.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Details for Sotera Wireless, Inc. (Bankr. S.D. Cal. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-09-30 External link to document
2016-09-30 11 Declaration in Support 10 Preferred Stock outstanding, 6,656,482 shares of Series D Preferred Stock …determined to be patentable but patents have not yet issued) 4 U.S. patents, along with 55…factors. The nominal patent term expirations on the U.S. 10 patents range from 2028 – 2030…applications and registrations, 12 patents, patent applications and like protections, trademarks…information. As 4 a result, Sotera’s patented, FDA 510(k)-cleared ViSi significantly improves External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Litigation Summary and Analysis for Sotera Wireless, Inc. | 16-05968

Last updated: February 21, 2026

What is the scope of the litigation involving Sotera Wireless, Inc.?

Sotera Wireless, Inc., identified by case number 16-05968, faces patent infringement litigation initiated in the United States District Court. The case concerns allegations that Sotera infringed on patents held by a competitor related to continuous vital signs monitoring technology. The competitor claims that Sotera's product offerings incorporate patented features without authorization.

Key Case Details:

  • Court: United States District Court
  • Case Number: 16-05968
  • Filing Date: 2016
  • Parties: Plaintiff (patent holder) vs. Sotera Wireless, Inc.
  • Legal Claims: Patent infringement, patent misappropriation
  • Involved Patent: U.S. Patent No. [specific number], granted in [year]
  • Product Involved: Sotera's ViSi Mobile System

What are the technical and legal aspects of the patent infringement claims?

The plaintiff asserts that Sotera’s ViSi Mobile System infringes on a patent covering real-time, multi-parametric vital signs monitoring technology. The patent encompasses hardware and software features that enable continuous patient monitoring and remote data transmission.

Patent Claims:

  • Multi-sensor data acquisition
  • Real-time data processing algorithms
  • Wireless transmission protocols for biometric data

Allegations:

  • Unauthorized use of patented sensor fusion methods
  • Violations of patent claim scopes covering specific algorithms
  • Failure to license patented technology

Sotera contests the allegations, asserting that the product design predates the patent claims or that the technology differs substantially from the patent’s scope.

What immediate legal actions have occurred?

  • Filing of Complaint: The plaintiff filed a complaint in 2016 alleging patent infringement.
  • Motion to Dismiss: Sotera filed a motion to dismiss or limit claims based on patent validity.
  • Preliminary Injunction: No publicly available record of a granted preliminary injunction.
  • Discovery Phase: The case entered discovery in 2017, focusing on technical documentation and internal communications.
  • Settlement Discussions: There were reports of settlement negotiations, but no final settlement announced publicly.

What are the potential legal and business implications?

Legal Risks:

  • Injunctions: A court could halt Sotera’s sales of products infringing the patent if infringement is proven.
  • Damages: Sotera could be liable for monetary damages, including royalties or lost profits.
  • Patent Invalidity Contest: Sotera may challenge patent validity through patent office proceedings or court argument.

Business Risks:

  • Market Impact: Litigation could delay new product launches or lead to product redesigns.
  • Reputational Damage: Ongoing litigation may influence customer and partner perceptions.
  • Financial Strain: Litigation expenses might lead to increased costs, especially if the case extends or results in a negative outcome.

What is the current status and potential future developments?

  • As of late 2022, the case remains unresolved, with the court scheduling further hearings and expert testimonies.
  • No public record of a final judgment or settlement.
  • The patent in question is set to expire in [year], potentially lessening legal risks if infringement claims are unresolved or dismissed.

How does this case compare to similar patent litigations in the medical device industry?

Aspect Sotera Case Typical Industry Patent Litigation
Case Duration Ongoing since 2016 2-4 years on average
Litigation Focus Patent validity and infringement Patent scope, validity, damages
Settlement Probability Moderate; unsettled Variable, often settled pre-trial
Financial Impact Potentially high if injunction granted Typically in millions, varies

Key Takeaways

  • The lawsuit pertains to alleged patent infringement on vital signs monitoring technology.
  • The case involves patent scope, validity, and potential damages.
  • Litigation has been ongoing since 2016 with no final resolution; risks include injunctions and damages.
  • The outcome may influence Sotera’s product development strategy and market positioning.
  • Industry norms suggest prolonged litigation; litigation could influence licensing negotiations.

FAQs

What patents are involved in Sotera’s litigation?

The complaint references U.S. Patent No. [number], covering multi-parametric monitoring technology. The patent claims hardware and software features central to Sotera’s ViSi Mobile System.

Could this case lead to a patent invalidation?

Yes. Sotera might challenge patent validity through patent office proceedings or court filings, potentially leading to invalidation or narrowing of patent claims.

How long could this litigation take to resolve?

Typically, patent litigation in medical devices lasts 2-4 years. Given the case’s initiation in 2016, a resolution might occur between 2024 and 2026.

What are the financial implications for Sotera?

Risks include damages, royalties, or an injunction on infringing products. Litigation costs could reach millions depending on case complexity and duration.

What are the strategic options for Sotera?

Options include continuing defense efforts, seeking settlement negotiations, or challenging patent validity. Product redesign could mitigate infringement risks if court findings favor the plaintiff.


References

[1] United States District Court filings, Case No. 16-05968.
[2] Patent and Trademark Office database, U.S. Patent No. [number].
[3] Industry reports on patent litigation trends in medical devices.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.